Background. There is controversy regarding the potential influence of vitamin D deficiency, exposure to environmental tobacco smoke, BCG vaccination, season, and body habitus on susceptibility to Mycobacterium tuberculosis (MTB) infection.
with increased risk of MTB infection. Population attributable fractions (PAFs) were then calculated for modifiable risk factors identified.
MATERIALS AND METHODS

Study Design, Setting, and Ethical Approval
We conducted a cross-sectional analysis of baseline data from children attending 18 public schools located in 6 districts of Ulaanbaatar, Mongolia (Bayanzurkh, Songino-Kharkhan, Bayangol, Khan-Uul, Chingeltei, and Sukhbaatar) who were being screened for participation in a randomized controlled trial of vitamin D supplementation for the prevention of MTB infection [14] . Mongolia is an East Asian country situated between China and Russia with a population of approximately 3.1 million people, of whom 1.2 million (39%) reside in the capital city, Ulaanbaatar. School attendance is mandatory for children aged 6-16 years. Incidence of active TB in Mongolia is estimated at 428 cases per 100 000 population per annum [15] , and prevalence of human immunodeficiency virus (HIV) infection is very low at 0.02% [16] . The study was approved by institutional review boards (IRBs) at the Mongolian Ministry of Health, the Mongolian National University, and the Harvard T. H. Chan School of Public Health (IRB reference number 14-0513).
Participants
Eligibility criteria were as for the clinical trial for which children were being screened [14] . Inclusion criteria were age 6-13 years at screening; provision of written informed assent to participate by the child; and provision of written informed consent for the child to participate from his/her parent/guardian. Exclusion criteria were known HIV seropositivity, primary hyperparathyroidism, sarcoidosis, or previous active or latent TB; taking cytotoxic therapy or other immunosuppressant medication, enzyme-inducing anticonvulsant therapy, cardiac glycoside, any preparation containing 1-α-hydroxylated vitamin D, or vitamin D supplementation of >10 µg/day; planning to move away from Ulaanbaatar within 4 years of enrollment; and presence of clinical signs of rickets, assessed by school doctors who checked for leg bowing, knock knees, pectus carinatum, and thickened wrists and ankles.
Data Collection and Measurements
Fieldworkers collected information from each child's parent for the following variables using an electronic questionnaire on the RedCAP database: age, sex, highest education level attained by either parent, type of residence, monthly household income, home ownership, number of people per room, indoor tobacco smoking in the household, active smoking by the child themselves, presence of an index case of pulmonary TB (PTB) living in the household during the child's lifetime, and the average amount of time the child spends outdoors per day. Height was measured to the nearest 0.1 cm using a portable stadiometer (SECA, Hamburg, Germany). Weight was measured to the nearest 0.1 kg using a Digital Floor Scale (SECA). BMI was calculated using the formula BMI = weight (kg) / (height [m] 2 ). Percentage body fat was estimated using a body composition analyzer (SC-331S, Tanita, Tokyo, Japan). School doctors ascertained the BCG status of participating children by clinical examination for a vaccination scar. One milliliter of venous blood was drawn into nil, TB antigen, and mitogen QuantiFERON-TB Gold High Altitude tubes (Qiagen, Hilden, Germany), which were processed as described below. Children with positive QuantiFERON-TB Gold results were referred to the Mongolia National Centre for Communicable Disease for clinical and radiographic screening for active TB. QuantiFERON-positive children in whom active TB was excluded were not preventively treated for latent tuberculosis, in line with World Health Organization recommendations [17] . The QuantiFERON-TB Gold assay was performed according to the manufacturer's instructions at the Global Laboratory, Ulaanbaatar, Mongolia, which participates in the QuantiFERON Quality Assurance Program of the Royal College of Pathologists of Australasia. Serum 25(OH)D concentrations were determined using an enzyme-linked fluorescent assay (VIDAS 25OH Vitamin D total, bioMérieux, Marcy-l'Étoile, France). The coefficient of variation was 7.9%, mean bias was 7.7%, and the limit of quantitation was 8.1 ng/mL. Nonzero 25(OH)D values were standardized using a set of 40 serum samples provided by the Vitamin D External Quality Assessment Scheme as previously described by the Vitamin D Standardization Program [18] . Values below the limit of quantitation were classified as <8.1 ng/ mL. Season-adjusted (deseasonalized) values were then calculated for each participant from their individual standardized 25(OH)D concentration and date of blood sample collection, using a sinusoidal model with values derived from standardized values for all participants [19] .
Statistical Analysis
Data were analyzed using SAS software version 9.4 (SAS Institute, Cary, North Carolina) and Stata software version 15 (StataCorp, College Station, Texas). Annual risk of TB infection (R) was estimated using the formula R = 1 − (1 − prevalence) 1/(mean age) [20] . The following factors were investigated as risk factors for QuantiFERON positivity, and handled as independent variables in the analysis: sex, age, parental education, type of residence, monthly household income, home ownership, number of people per room, month of sampling, number of people smoking cigarettes in the home, active smoking by the child, presence of BCG scar, BMI, percentage body fat, household exposure to an index case of PTB, time spent outdoors, and vitamin D deficiency, defined as serum 25(OH)D concentration <10 ng/mL; this threshold was prespecified, based on findings of a previous study that reported susceptibility to M. tuberculosis infection to be increased below this cutoff [5] . Risk ratios (RRs) for the association between these independent variables and the dependent variable of MTB infection (categorized as QuantiFERON positive vs negative) were estimated using generalized estimating equations with the binary distribution, log link function, and exchangeable working correlation structure [21] . When the log-binomial model failed to converge, log-Poisson models, which provide consistent but not fully efficient estimates of the RR and its confidence interval (CI), were used [22] . We conducted 2 multivariable analyses to identify factors that were independently associated with risk of MTB infection: one adjusted for age and sex only, and the other additionally adjusted for all covariates that were associated with QuantiFERON positivity with P < .20 in the age-and sex-adjusted analysis. PAFs and their 95% CI were calculated for modifiable risk factors for MTB infection using Stata software as previously described [23] . Participants with indeterminate QuantiFERON results (n = 4) were excluded from analyses of risk factors for MTB infection.
RESULTS
A total of 11 475 children were invited to participate in the study from July 2015 to January 2017, of whom 1065 (9.3%) declined and 596 (5.2%) were ineligible; reasons for ineligibility are presented in Supplementary Of the 9814 children who underwent QuantiFERON testing, 8864 (90.3%) had a negative result, 946 (9.6%) had a positive result, and 4 (0.04%) had an indeterminate result and were excluded from analyses. Based on a mean participant age of 9.4 years, the annual risk of TB infection (R) estimated using the formula R = 1 − (1 − prevalence) 1/(mean age) was 1.1% [20] .
Nine hundred thirty-eight of the 946 QuantiFERON-positive children (99.2%) were screened for active TB; of these, 129 (13.8%) were diagnosed with active TB. Table 2 ).
In a subset of 373 children with a history of household exposure to an index case of PTB, risk of QFT positivity was independently associated with the total number of index cases to whom the child had been exposed (aRR per additional index case, 1.72 [95% CI, 1.33-2.23], P < .001) and increasing age (aRR per additional year, 1.08 [95% CI, 1.01-1.16], P = .04), but not with any other potential risk factor investigated (Table 3) . 
DISCUSSION
We present results of the largest and most comprehensive study investigating risk factors for MTB infection in children conducted to date, and the first such investigation to be done in Mongolia. In a representative population of schoolchildren aged 6-13 years living in the capital city, Ulaanbaatar, we found that household contact with a case of PTB, vitamin D deficiency, household exposure to environmental tobacco smoke, and increasing age were independent risk factors for infection. We found no association between risk of MTB infection and gender, socioeconomic factors, presence of BCG scar, season, or BMI.
Our study has several positive findings. The observation that MTB infection risk is associated with household contact and increasing age is consistent with results from community-based studies and household contact studies in the literature [1] . The former finding emphasizes the importance of efforts to protect children from MTB infection in the home, and highlights the potential for a policy of household contact tracing with provision of preventive therapy to reduce the population-level burden of TB in low-and middle-income countries [17, 24, 25] . Demonstration of an independent association between household exposure to environmental tobacco smoke and increased risk of MTB infection suggests that this (5) Defined as the presence of at least one person other than the participating child smoking indoors (6) P-value for trend association is not explained by confounding due to socioeconomic factors, as has previously been suggested [12] . The case for a causal interpretation is further supported by our demonstration of a dose-response relationship between increasing number of people per household smoking indoors and increasing risk of QuantiFERON positivity and by results of mechanistic studies showing that tobacco smoke attenuates innate immune responses to MTB both in vitro and in vivo [26] [27] [28] [29] . Vitamin D metabolites have also been shown to support innate immune responses to MTB in vitro [30, 31] , and our finding of an independent association between vitamin D deficiency and QuantiFERON positivity supports the case for conducting clinical trials of vitamin D supplementation to prevent acquisition of MTB infection, 2 of which are currently in progress [14, 32] . With regard to the magnitude of protective associations observed, we found that 13.1% of the risk of acquiring MTB infection was attributable to household TB contact. This figure is similar to that reported from a meta-analysis of 10 studies, which yielded an estimate of 14.1% (95% CI, 11.6%-16.3%) for the PAF for household transmission [33] . This relatively low figure reflects the fact that TB disease affects <1% of households at any time, even in high-incidence settings, making exposure opportunities between a person with TB and their social network outside the household more numerous [34] . Studies in South Africa have indicated that significant transmission occurs in public transportation [35] and in schools [36] . Further study to investigate sites of TB transmission in community settings in Mongolia is needed. The relatively high PAF for passive smoking (7.0%) demonstrated in our study is also striking: it highlights the importance of tobacco control for TB prevention [37] . The PAF for vitamin D deficiency (5.7%) echoes results of a recent ecological analysis, indicating that 6.3% of global variation in tuberculosis incidence is attributable to variations in exposure to ultraviolet-B radiation [38] , which is a key determinant of vitamin D status.
Our study also has some important null findings. In contrast to others [2, 3] , we did not find that presence of a BCG scar was associated with protection against MTB infection. In considering the significance of this observation, it is important to note that absence of a BCG scar does not necessarily signify that BCG vaccine was not given, as a proportion of BCG-vaccinated children do not develop a scar. Coverage of BCG vaccination has been estimated to be as high as 98.6% in Mongolia [39] ; thus, children without BCG scars in this study may have been vaccinated. The fact that we found no statistically significant association between active smoking and risk of MTB infection may be explained by a lack of statistical power to detect such an association, reflecting the rarity of this practice: Just 49 of 9810 (0.5%) participants smoked cigarettes. Accordingly, the 95% CI for the RR for active smoking was very wide (.10-1.57).
Our study has a number of strengths. Our use of the QuantiFERON test (as opposed to tuberculin skin test) to detect MTB infection allowed for MTB infection status to be evaluated without confounding by sensitization to BCG or environmental mycobacteria. The sample size was very large, reducing the potential for type 2 error, and we recorded detailed information on a wide range of potential determinants of infection risk, allowing for comprehensive adjustment for confounders. We employed an objective assessment of BCG status (presence vs absence of BCG scar, evaluated by school doctors) rather than a subjective assessment such as eliciting a history of BCG vaccination. The laboratory performing QuantiFERON tests participated in an external quality assurance scheme performed by an ISO 9001-accredited laboratory, and rates of indeterminate results were extremely low (0.04%).
Our study also has some limitations. As with any observational study, associations observed may be due to residual and/ or unmeasured confounding. However, the associations that we report are all biologically plausible and independent, withstanding adjustment for a wide range of potential confounders; moreover, a dose-response relationship is seen for some risk factors (eg, age, number of TB contacts, number of people per household smoking cigarettes indoors). All of these factors strengthen the case for causal inference. A second potential limitation is that the study was a cross-sectional analysis of baseline data from clinical trial participants: if this approach had resulted in exclusion of significant numbers of children, it could have compromised generalizability of our findings. However, participation rates in our study were high (85.5%), comparing favorably with those of cross-sectional studies investigating prevalence of MTB infection in other settings [40] . A third limitation is that we did not test for HIV infection; however, the prevalence of HIV infection in Mongolia is very low at 0.02% [16] .
In conclusion, this very large, cross-sectional analysis identifies household contact with an index case of PTB, vitamin D deficiency, and passive smoking as potentially modifiable risk factors for QuantiFERON-diagnosed MTB infection among Mongolian schoolchildren.
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